The DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Exposure of Adolescent Rats to Oral Methylphenidate: Preferential Effects on Extracellular Norepinephrine and Absence of Sensitization and Cross-Sensitization to Methamphetamine
Open accessAbstract
Methylphenidate (MP) (ritalin) is widely used in the treatment of children and adolescents with attention deficit hyperactivity disorder, but little is known about therapeutic mechanisms or about possible consequences of long-term exposure. To more closely simulate the clinical use of the drug, we orally administered MP to adolescent rats during the dark-active phase of the circadian cycle at doses (0.75-3.0 mg/kg) below threshold for locomotor activation. We found that doses in this range increased extracellular norepinephrine in hippocampus without affecting dopamine in nucleus accumbens. These results suggest that norepinephrine systems may play an important role in the therapeutic action of this drug. To examine one potential consequence of long-term exposure to MP, i.e., the development of locomotor sensitization, an adaptational change that has been implicated in drug abuse liability, animals received three daily oral administrations of these doses of MP for up to 4 weeks through adolescence. The animals were then challenged with methamphetamine (0.5 mg/kg). We found that the behavioral response to MP did not change during the course of chronic treatment and that MP-pretreated animals did not exhibit a sensitized locomotor response to the methamphetamine challenge. We propose that, to the extent that this treatment protocol more closely reflects clinical exposure patterns, the relative insensitivity of accumbens dopamine to the acute administration of these MP doses, and the corresponding absence of evidence for the development of locomotor sensitization, supports one clinical view that there is little abuse liability associated with low dose, long-term MP treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“These lower doses in rats improve PFC attention and working memory function, enhance PFC neuronal response, and reduce locomotor hyperactivity in juveniles (Arnsten and Dudley, 2005; Berridge et al., 2006; Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Kuczenski and Segal, 2002
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“When administered in appropriate doses, these medications improve PFC function both in healthy human subjects (Elliott et al., 1997) and in animals (Arnsten and Dudley, 2005), including the reduction of locomotor hyperactivity in juvenile rats (Kuczenski and Segal, 2002).”
From Catecholamine influences on prefrontal cortical function: Relevance to treatment of attention deficit/hyperactivity disorder and related disorders (2011) · cites this paper as Kuczenski and Segal, 2002
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neural basis of drug craving: An incentive-sensitization theory of addiction
Robinson, T. (1993) · Brain Research Reviews · doi:10.1016/0165-0173(93)90013-p · Cited by 7,346
Robinson, T. G., & BECKER, J. (1986) · Brain Research · doi:10.1016/s0006-8993(86)80193-7 · Cited by 2,108
Robinson, T. E., & Becker, J. B. (1986) · Brain Research Reviews · doi:10.1016/0165-0173(86)90002-0 · Cited by 1,796
Biederman, J. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.5.816 · Cited by 1,498
Vanderschuren, L. J. M. J., & Kalivas, P. W. (2000) · Psychopharmacology · doi:10.1007/s002130000493 · Cited by 1,360
A circuitry model of the expression of behavioral sensitization to amphetamine-like psychostimulants
Pierce, R. C., & Kalivas, P. W. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(97)00021-0 · Cited by 1,239
Volkow, N. D., Wang, G.-J., Fowler, J. S., Gatley, S. J., Logan, J., Ding, Y.-S., Hitzemann, R., & Pappas, N. (1998) · American Journal of Psychiatry · doi:10.1176/ajp.155.10.1325 · Cited by 885
D1 receptors in prefrontal cells and circuits
Goldman-Rakic, P. (2000) · Brain Research Reviews · doi:10.1016/s0165-0173(99)00045-4 · Cited by 822
Volkow, N. D., Wang, G.-J., Fowler, J. S., Logan, J., Gerasimov, M., Maynard, L., Ding, Y.-S., Gatley, S. J., Gifford, A., & Franceschi, D. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-02-j0001.2001 · Cited by 770
Michelson, D., Faries, D., Wernicke, J., Kelsey, D., Kendrick, K., Sallee, F. R., Spencer, T., & the Atomoxetine ADHD Study Group (2001) · Pediatrics · doi:10.1542/peds.108.5.e83 · Cited by 666
Research works printed but not linked: 3
- Sagvolden T (2001) The spontaneously hypertensive rat as a model for ADHD. In: Stimulant drugs and ADHD: basic and clinical neuro- science (Solanto MV, Arnsten AFT, Castellanos FX, eds), pp 221-237. New York: Oxford UP.
- Solanto MV, Arnsten AFT, Castellanos FX (2001) The neuroscience of stimulant drugs in ADHD. In: Stimulant drugs and ADHD: basic and clinical neuroscience (Solanto MV, Arnsten AFT, Castellanos FX, eds), pp 355-379. New York: Oxford UP.
- Taylor JR, Jentsch JD (2001) Stimulant effects on striatal and cortical dopamine systems involved in reward-related behavior and impulsivity: implications for ADHD. In: Stimulant drugs and ADHD: basic and clinical neuroscience (Solanto MV, Arnsten AFT, Castellanos FX, eds), pp 104 -133. New York: Oxford UP.
Cited by
Sorted by citations
Items 101–200 of 317
Comim, C. M., Gomes, K. M., Réus, G. Z., Petronilho, F. C., Ferreira, G. K., STRECK, E. L., Dal‐Pizzol, F., & Quevedo, J. (2013) · Acta Neuropsychiatrica · doi:10.1017/neu.2013.35 · Cited by 47
Motaghinejad, M., Motevalian, M., Shabab, B., & Fatima, S. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-016-1623-5 · Cited by 46
Schmeichel, B. E., & Berridge, C. W. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2013.6 · Cited by 43
Animal models to guide clinical drug development in ADHD: lost in translation?
Wickens, J. R., Hyland, B. I., & Tripp, G. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01412.x · Cited by 45
Andersen, S. L., Napierata, L., Brenhouse, H. C., & Sonntag, K. (2008) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2008.06254.x · Cited by 44
Impairment of single-trial memory formation by oral methylphenidate in the rat
CHUHAN, Y., & TAUKULIS, H. (2005) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2005.09.001 · Cited by 44
Characterization of methylphenidate self-administration and reinstatement in the rat
Botly, L. C. P., Burton, C. L., Rizos, Z., & Fletcher, P. J. (2008) · Psychopharmacology · doi:10.1007/s00213-008-1093-z · Cited by 43
Zhu, J., Spencer, T. J., Liu‐Chen, L., Biederman, J., & Bhide, P. G. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.04.015 · Cited by 42
Kline, R. L., Zhang, S., Farr, O. M., Hu, S., Záborszky, L., Samanez-Larkin, G. R., & Li, C. R. (2016) · Frontiers in Human Neuroscience · doi:10.3389/fnhum.2016.00149 · Cited by 43
Jezierski, G., Zehle, S., Bock, J., Braun, K., & Gruss, M. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.04927.x · Cited by 41
Methylphenidate improves performance on the radial arm maze in periadolescent rats
Dow-Edwards, D. L., Weedon, J. C., & Hellmann, E. (2008) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2008.04.001 · Cited by 41
Shen, R., & Choong, K.-C. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.08.021 · Cited by 39
Jordan, C. J., Harvey, R. C., Baskin, B. B., Dwoskin, L. P., & Kantak, K. M. (2014) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2014.04.020 · Cited by 38
Beaudin, S. A., Strupp, B. J., Lasley, S. M., Fornal, C. A., Mandal, S., & Smith, D. R. (2015) · Toxicological Sciences · doi:10.1093/toxsci/kfv007 · Cited by 38
Swearingen, D., Pennick, M., Shojaei, A., Lyne, A., & Fiske, K. S. (2007) · Clinical Therapeutics · doi:10.1016/j.clinthera.2007.04.016 · Cited by 38
Andersen, S. L., & Navalta, C. P. (2011) · Journal of Child Psychology and Psychiatry · doi:10.1111/j.1469-7610.2011.02376.x · Cited by 40
FERON, F. J. M., Hendriksen, J. G. M., van Kroonenburgh, M. J. P. G., Blom-Coenjaerts, C., Kessels, A. G. H., Jolles, J., Weber, W. E. J., & Vles, J. S. H. (2005) · Pediatric Neurology · doi:10.1016/j.pediatrneurol.2005.04.008 · Cited by 38
Animal model of methylphenidate's long-term memory-enhancing effectsPreprint
Carmack, S., Howell, K. K., Rasaei, K., Reas, E. T., & Anagnostaras, S. (2014) · Learning & Memory · doi:10.1101/lm.033613.113 · Cited by 41
Somkuwar, S. S., Darna, M., Kantak, K. M., & Dwoskin, L. P. (2013) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.04.013 · Cited by 37
Robison, L. S., Ananth, M. R., Hadjiargyrou, M., Komatsu, D. E., & Thanos, P. K. (2017) · Journal of Neural Transmission · doi:10.1007/s00702-017-1680-4 · Cited by 37
Choong, K.-C., & Shen, R. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.060657 · Cited by 37
The Role of Alpha2-Adrenergic Agonists in Attention-Deficit/Hyperactivity Disorder
Sallee, F. R. (2010) · Postgraduate Medicine · doi:10.3810/pgm.2010.09.2204 · Cited by 36
Bethancourt, J. A., Camarena, Z. Z., & Britton, G. B. (2009) · Behavioural Brain Research · doi:10.1016/j.bbr.2009.03.015 · Cited by 39
Schmitz, F., Pierozan, P., Rodrigues, A. F., Biasibetti, H., Grunevald, M., Pettenuzzo, L. F., Scaini, G., STRECK, E. L., Netto, C. A., & Wyse, Â. T. D. S. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-9987-y · Cited by 38
Schmitz, F., Pierozan, P., Rodrigues, A. F., Biasibetti, H., Grings, M., Zanotto, B., Coelho, D. M., Vargas, C. R., Leipnitz, G., & Wyse, A. T. S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0289-1 · Cited by 35
Methylphenidate effects in the young brain: friend or foe?
Loureiro‐Vieira, S., Costa, V. M., Bastos, M. D. L., Carvalho, F. D., & Capela, J. P. (2017) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2017.04.002 · Cited by 37
Stevens, T., Sangkuhl, K., Brown, J. T., Altman, R. B., & Klein, T. E. (2019) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0000000000000376 · Cited by 37
Chong, S. L., Claussen, C. M., & Dafny, N. (2012) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2012.01.004 · Cited by 34
Harvey, R. C., Jordan, C. J., Tassin, D. H., Moody, K. R., Dwoskin, L. P., & Kantak, K. M. (2013) · Behavioural Brain Research · doi:10.1016/j.bbr.2013.01.027 · Cited by 34
Somkuwar, S. S., Kantak, K. M., Bardo, M. T., & Dwoskin, L. P. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.12.002 · Cited by 34
COMT Val108/158Met Polymorphism and the Modulation of Task-Oriented Behavior in Children with ADHD
Sengupta, S. M., Grizenko, N., Schmitz, N., Schwartz, G. J., Bellingham, J., Polotskaia, A., Ter-Stepanian, M., Goto, Y., Grace, A. A., & Joober, R. (2008) · Neuropsychopharmacology · doi:10.1038/npp.2008.85 · Cited by 34
Reinforcement, Dopamine and Rodent Models in Drug Development for ADHD
Tripp, G., & Wickens, J. R. (2012) · Neurotherapeutics · doi:10.1007/s13311-012-0132-y · Cited by 36
van der Marel, K., Bouët, V., Meerhoff, G. F., Fréret, T., Boulouard, M., Dauphin, F., Klomp, A., Lucassen, P. J., Homberg, J. R., Dijkhuizen, R. M., et al. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.04.044 · Cited by 34
Rozas, C., Carvallo, C., Contreras, D., Carreño, M., Ugarte, G., Delgado, R., Zeise, M. L., & Morales, B. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.07.003 · Cited by 31
Fagundes, A. O., Scaini, G., Santos, P. M. L., Sachet, M. U., Bernhardt, N. M., Rezin, G. T., Valvassori, S. S., Schuck, P. F., Quevedo, J., & STRECK, E. L. (2009) · Neurochemical Research · doi:10.1007/s11064-009-0069-7 · Cited by 31
Oral methylphenidate improves spatial learning and memory in pre- and periadolescent rats.
Zhu, N. W., Weedon, J., & Dow-Edwards, D. L. (2007) · Behavioral Neuroscience · doi:10.1037/0735-7044.121.6.1272 · Cited by 31
KEAGE, H. A. D., CLARK, C. R., HERMENS, D. F., KOHN, M. R., CLARKE, S., WILLIAMS, L. M., CREWTHER, D., LAMB, C., & GORDON, E. (2006) · Journal of Integrative Neuroscience · doi:10.1142/s0219635206001070 · Cited by 30
Phan, N. T. N., Hanrieder, J., Berglund, E. C., & Ewing, A. G. (2013) · Analytical Chemistry · doi:10.1021/ac401920v · Cited by 30
A novel method for oral stimulant administration in the neonate rat and similar species
Wheeler, T. L., Eppolito, A. K., Smith, L. N., Huff, T. B., & Smith, R. F. (2006) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2006.07.019 · Cited by 31
The Neurobiology of Attention-Deficit/Hyperactivity Disorder
Fischman, A. J., & Madras, B. K. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.035 · Cited by 30
NTP-CERHR Expert Panel Report on the reproductive and developmental toxicity of methylphenidate
Golub, M. S., Costa, L. G., Crofton, K. M., Frank, D. A., Fried, P. A., Gladen, B. C., Henderson, R. F., Liebelt, E. L., Lusskin, S. I., Marty, S., et al. (2005) · Birth Defects Research Part B Developmental and Reproductive Toxicology · doi:10.1002/bdrb.20049 · Cited by 28
Acute and sub-chronic functional neurotoxicity of methylphenidate on neural networks in vitro
Gopal, K. V., Miller, B., & Gross, G. W. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0759-8 · Cited by 28
Berglund, E. C., Makos, M. A., Keighron, J. D., Phan, N. T. N., Heien, M. L., & Ewing, A. G. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn3002009 · Cited by 26
Fagundes, A. O., Aguiar, M. R., Aguiar, C. S., Scaini, G., Sachet, M. U., Bernhardt, N. M., Rezin, G. T., Valvassori, S. S., Quevedo, J., & STRECK, E. L. (2010) · Neurochemical Research · doi:10.1007/s11064-010-0229-9 · Cited by 27
Methylphenidate differentially regulates c-fos and fosB expression in the developing rat striatum
Chase, T. D., CARREY, N. J., Brown, R. E., & Wilkinson, M. (2005) · Developmental Brain Research · doi:10.1016/j.devbrainres.2005.04.003 · Cited by 27
From neurons to brain networks, pharmacodynamics of stimulant medication for ADHD
Parlatini, V., Bellato, A., Murphy, D., & Cortese, S. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105841 · Cited by 26
Effects of atomoxetine on locomotor activity and impulsivity in the spontaneously hypertensive rat
Turner, M., Wilding, E., Cassidy, E., & Dommett, E. J. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.12.025 · Cited by 27
Britton, G. B., & Bethancourt, J. A. (2009) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2009.06.007 · Cited by 26
Andrzejewski, M. E., Spencer, R. C., Harris, R. L., Feit, E. C., McKee, B. L., & Berridge, C. W. (2014) · Neuropharmacology · doi:10.1016/j.neuropharm.2014.01.018 · Cited by 24
Juvenile methylphenidate exposure and factors that influence incentive processing
Brenhouse, H. C., Napierata, L., Kussmaul, L., Leussis, M., & Andersen, S. L. (2009) · Developmental Neuroscience · doi:10.1159/000207498 · Cited by 24
Methylphenidate improves cognitive deficits produced by infantile iron deficiency in rats
Mohamed, W. M. Y., Unger, E. L., Kambhampati, S., & Jones, B. C. (2010) · Behavioural Brain Research · doi:10.1016/j.bbr.2010.07.025 · Cited by 24
Schmitz, F., Pierozan, P., Rodrigues, A. F., Biasibetti, H., Coelho, D. D. M., Mussulini, B. H. M., Pereira, M. S. L., Parisi, M. M., Barbé‐Tuana, F. M., de Oliveira, D. L., et al. (2015) · Molecular Neurobiology · doi:10.1007/s12035-015-9219-x · Cited by 24
Wanchoo, S. J., Lee, M. J., Swann, A. C., & Dafny, N. (2009) · Brain Research · doi:10.1016/j.brainres.2009.11.035 · Cited by 23
Somkuwar, S. S., Kantak, K. M., & Dwoskin, L. P. (2015) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2015.02.002 · Cited by 23
Berridge, C., & Arnsten, A. (2015) · Current Opinion in Behavioral Sciences · doi:10.1016/j.cobeha.2015.01.002 · Cited by 24
Cocaine responsiveness or anhedonia in rats treated with methylphenidate during adolescence
Ferguson, S. A., & Boctor, S. Y. (2010) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2010.03.007 · Cited by 23
Elevated Anxiety and Impaired Attention in Super-Smeller, Kv1.3 Knockout Mice
Huang, Z., Hoffman, C. A., Chelette, B. M., Thiebaud, N., & Fadool, D. A. (2018) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2018.00049 · Cited by 20
Zhu, N. W., Weedon, J., & Dow-Edwards, D. L. (2010) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2009.12.004 · Cited by 22
A review of psychostimulant-induced neuroadaptation in developing animals
CARREY, N. J., & Wilkinson, M. (2011) · Neuroscience Bulletin · doi:10.1007/s12264-011-1004-x · Cited by 21
Urban, K. R., & Gao, W. (2013) · Medical Hypotheses · doi:10.1016/j.mehy.2013.09.009 · Cited by 20
Baskin, B. M., Dwoskin, L. P., & Kantak, K. M. (2015) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2015.01.019 · Cited by 20
Yang, P. B., Swann, A. C., & Dafny, N. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.03.007 · Cited by 20
Quansah, E., Sgamma, T., Jaddoa, E., & Zetterström, T. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.06.012 · Cited by 20
Dommett, E. J. (2014) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2014.06.001 · Cited by 21
LeBlanc-Duchin, D., & Taukulis, H. K. (2009) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2008.12.004 · Cited by 19
LeBlanc-Duchin, D., & TAUKULIS, H. (2004) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2004.09.021 · Cited by 19
Quansah, E., Ruiz‐Rodado, V., Grootveld, M. C., Probert, F., & Zetterström, T. (2017) · Neurochemistry International · doi:10.1016/j.neuint.2017.03.003 · Cited by 18
The cognitive and behavioral effects of D-amphetamine and nicotine sensitization in adult zebrafish
Cleal, M., Fontana, B. D., & Parker, M. O. (2021) · Psychopharmacology · doi:10.1007/s00213-021-05844-5 · Cited by 20
Frolov, A., Reyes-Vasquez, C., & Dafny, N. (2014) · Journal of Neurophysiology · doi:10.1152/jn.00633.2013 · Cited by 18
Neurobiology of Attention Deficit Hyperactivity Disorder
Faraone, S. V., Bhide, P. G., & Biederman, J. (2017) · Oxford University Press eBooks · doi:10.1093/med/9780190681425.003.0064 · Cited by 18
Diurnal differences in memory and learning in young and adult rats treated with methylphenidate
Gomes, K. M., Comim, C., Valvassori, S., Réus, G. Z., Inácio, C. G., Martins, M. R., Souza, R. P., & Quevedo, J. (2010) · Journal of neural transmission · doi:10.1007/s00702-010-0385-8 · Cited by 19
Evolution of the Study of Methylphenidate and Its Actions on the Adult Versus Juvenile Brain
Urban, K. R., & Gao, W. (2012) · Journal of Attention Disorders · doi:10.1177/1087054712455504 · Cited by 18
Venkataraman, S. S., Claussen, C. M., Kharas, N., & Dafny, N. (2020) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2019.10.009 · Cited by 17
Gronier, B., James, A., Liauzun, C., & Zetterström, T. (2010) · Journal of Psychopharmacology · doi:10.1177/0269881109359100 · Cited by 17
Methylphenidate alleviates manganese-induced impulsivity but not distractibility
Beaudin, S. A., Strupp, B. J., Uribe, W., Ysais, L., Strawderman, M. S., & Smith, D. R. (2017) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2017.03.005 · Cited by 17
Karim, T. J., Reyes-Vázquez, C., & Dafny, N. (2017) · Journal of Neurophysiology · doi:10.1152/jn.00145.2017 · Cited by 17
Quansah, E., & Zetterström, T. (2019) · Neurochemistry International · doi:10.1016/j.neuint.2019.01.016 · Cited by 17
Faltraco, F., Palm, D., Uzoni, A., Borchert, L., Simon, F. A. J., Tucha, O. M., & Thome, J. (2021) · Journal of Neural Transmission · doi:10.1007/s00702-021-02374-4 · Cited by 18
Levant, B., Zarcone, T. J., Davis, P. F., Ozias, M. K., & Fowler, S. C. (2010) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.110.174425 · Cited by 16
Agster, K. L., Clark, B., Gao, W., Shumsky, J. S., Wang, H. X., Berridge, C. W., & Waterhouse, B. D. (2011) · The Anatomical Record · doi:10.1002/ar.21403 · Cited by 16
Examination of methylphenidate-mediated behavior regulation by glycogen synthase kinase-3 in mice
Mines, M. A., Beurel, E., & Jope, R. S. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.10.018 · Cited by 16
Wheeler, T. L., Smith, L. N., Bachus, S. E., McDonald, C. G., Fryxell, K. J., & Smith, R. F. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.12.005 · Cited by 16
Pardey, M. C., Kumar, N. N., Goodchild, A. K., Clemens, K. J., Homewood, J., & Cornish, J. L. (2012) · Brain Sciences · doi:10.3390/brainsci2030375 · Cited by 17
Miller, E. M., Quintero, J. E., Pomerleau, F., Huettl, P. F., Gerhardt, G. A., & Glaser, P. E. A. (2018) · Neurochemical Research · doi:10.1007/s11064-018-2483-1 · Cited by 16
Philipsen, M. H., Phan, N. T. N., Fletcher, J. S., & Ewing, A. G. (2020) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.0c00014 · Cited by 16
Britton, G. B. (2011) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145711000472 · Cited by 18
Behavioral, Neurochemical and Developmental Effects of Chronic Oral Methylphenidate: A Review
Senior, D., Ahmed, R., Arnavut, E., Carvalho, A. T. P., Lee, W. X., Blum, K., Komatsu, D. E., Hadjiargyrou, M., Badgaiyan, R. D., & Thanos, P. K. (2023) · Journal of Personalized Medicine · doi:10.3390/jpm13040574 · Cited by 15
Chronic methylphenidate exposure during adolescence reduces striatal synaptic responses to ethanol
Crowley, N. A., Cody, P. A., Davis, M. I., Lovinger, D. M., & Mateo, Y. (2013) · European Journal of Neuroscience · doi:10.1111/ejn.12426 · Cited by 15
Grund, T., Teuchert, G., Busche, A., Neddens, J., Brummelte, S., Moll, G. H., & Dawirs, R. R. (2007) · Brain Research · doi:10.1016/j.brainres.2007.06.107 · Cited by 15
Bahçelioğlu, M., Gözil, R., Take, G., Elmas, Ç., Öktem, H., Kadioglu, D., Çalgüner, E., Erdoğan, D., Sargon, M. F., Yazıcı, A. C., et al. (2009) · The World Journal of Biological Psychiatry · doi:10.1080/15622970903176683 · Cited by 15
Isolation rearing as a preclinical model of attention/deficit-hyperactivity disorder
Yates, J. R., Darna, M., Gipson, C., Dwoskin, L., & Bardo, M. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.04.043 · Cited by 14
Justo, C. C., Carneiro-de-Oliveira, P. E., DeLucia, R., Aizenstein, M. L., & Planeta, C. S. (2010) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2010007500042 · Cited by 12
Sterley, T.-L., Howells, F. M., & Russell, V. A. (2015) · Brain Research · doi:10.1016/j.brainres.2015.11.019 · Cited by 14
Loureiro‐Vieira, S., Costa, V. M., Duarte, J. A., Duarte‐Araújo, M., Gonçalves‐Monteiro, S., de Lourdes, B. M., Carvalho, F. D., & Capela, J. P. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.017 · Cited by 14
Effects of perinatal methylphenidate (MPH) treatment in male and female Sprague–Dawley offspring
Panos, J., Law, C., & Ferguson, S. A. (2014) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2014.01.004 · Cited by 14
The Neurobiological Basis of Attention-Deficit/Hyperactivity Disorder
Arnsten, A. F. T., Berridge, C. W., & McCracken, J. T. (2009) · Primary psychiatry · Cited by 14
Schmitz, F., Pierozan, P., Biasibetti, H., Ferreira, F. S., Petry, F. D. S., Trindade, V. M. T., Pessoa‐Pureur, R., & Wyse, Â. T. D. S. (2017) · Metabolic Brain Disease · doi:10.1007/s11011-017-0177-z · Cited by 14
Chronic methylphenidate treatment during adolescence has long-term effects on monoaminergic function
Miceli, M. D., Omoloye, A., & Gronier, B. (2018) · Journal of Psychopharmacology · doi:10.1177/0269881118805494 · Cited by 14
Suzuki, T., Shindo, K., Miyatake, M., Kurokawa, K., Higashiyama, K., Suzuki, M., & Narita, M. (2007) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2007.06.062 · Cited by 14
Lee, M. J., Yang, P. B., Wilcox, V. T., Burau, K. D., Swann, A. C., & Dafny, N. (2010) · Journal of Neural Transmission · doi:10.1007/s00702-010-0510-8 · Cited by 13
Metadata
- Authors
- Kuczenski, R., & Segal, D. S.
- Affiliations
- University of California San Diego (US)
- Venue
- The Journal of Neuroscience
- Publisher
- Society for Neuroscience
- Published
- 2002-08-15
- Volume
- 22
- Issue
- 16
- Pages
- 7264-7271
- ISSN
- 0270-6474 (ISSN-L)
- 1529-2401
- PMC
- PMC6757883
- OpenAlex
- W2159875740
- Cited by
- 316
- References
- 75
- Citations by year
- 2026: 5 · 2025: 5 · 2024: 7 · 2023: 5 · 2022: 5 · 2021: 7 · 2020: 7 · 2019: 6 · 2018: 12 · 2017: 12 · 2016: 10 · 2015: 28 · 2014: 16 · 2013: 21 · 2012: 21
- FWCI
- 4.66
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Neuroscience (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- U.S. Department of Veterans Affairs
- University of California, San Diego
- National Institute on Drug Abuse (R01DA001568)
- NIH Clinical Center
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Keywords
- methylphenidate, adolescent rats, hippocampus, nucleus accumbens dopamine, locomotor sensitization, cross-sensitization, abuse liability, attention deficit hyperactivity disorder, long-term drug exposure
- MeSH terms
- Administration, Oral, Age Factors, Animals, Behavior, Animal, Dopamine, Dose-Response Relationship, Drug, Drug Administration Schedule, Drug Interactions, Extracellular Space, Hippocampus, Male, Methamphetamine, Methylphenidate, Motor Activity, Norepinephrine, Nucleus Accumbens, Time, Rats, Sprague-Dawley, Microdialysis, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review